Feedback Share Discussion Threads

[georgesorearse] 25/8/2019 14:25

Hazl - I read that on LSE as well : )

[hazl] 25/8/2019 14:21

I'm excited!

[ducatiman] 25/8/2019 14:20

Correct hazl and he said he was excited!

[hazl] 25/8/2019 14:19

Again if you draw a straight line on the chart through the lows since June

you can see that is been a RISING price!


Nothing goes up in a straight line.

[hazl] 25/8/2019 14:16

Indeed ducat man somebody on LSE was talking about
Tom Oakley having said in the recent proactive interview how Bleepa will be launched first and then a #Texrad announcement after that.

Apparently there was a Tex rad update to be made but it had to come after Bleepa's.

I can see what he is getting at and that Bleepa would be a stronger product if Texrad and Bleepa are a combined entity to for Bleepa in the health care imaging market place.

[ducatiman] 25/8/2019 10:23

Let's see where the share price is at the end of Sept!

[lr2] 25/8/2019 10:21

Meanwhile the share has declined since the end of July.

I think we can complain about that.

[hazl] 25/8/2019 10:10

Meanwhile the share has climbed since July


I don't think we can complain about that.

[georgesorearse] 25/8/2019 09:55

Daveydoo ... I only need to own one share to have a voice ... good , well run BODs interact effectively with all stockholders.... Let's hope Tom Oakley steps up and becomes his own man...not a puppet with someones hand making his mouth work.

[ducatiman] 24/8/2019 15:42

Ged, good post. In essence a full update is required in order to answer the poignant questions being asked by shareholders.

[bobd29] 24/8/2019 15:14

Hi Ged5, very valid post imo. AR specified the timeframe for FDA approval so it is beholding to him to provide an update as we approach that timeframe. I am assuming TO will cover this aspect in his TexRAD review which is due imminently, but as shareholders we rightfully expect the BOD to keep us updated.....so as I said, good post.

[newtothisgame3] 24/8/2019 13:58

#FDBK @FBKmed Feedback Medical
?

@FBKmed
5h5 hours ago

Our CEO Dr Tom Oakley explains why @BleepaMe is more than just a messaging app:

[hazl] 24/8/2019 13:52

I understand the climate has changed over in America, with regard to the ease or otherwise, in getting FDA approval for companies products that emanate from outside of the US.
I have no idea but it makes sense in this particular time.
If this is reality, the company themselves, cannot necessarily be blamed.

[ged5] 24/8/2019 12:47

Davy, I don't expect an on demand personal dialogue with the CEO at any time but I do expect questions to be answered and certainly an acknowledgement of emails. Are you telling me the email responses so far have not been helpful?

I have run threads for other companies and have always received replies to emails or phone calls. In one company there are least 2 directors who answer shareholders questions without delay and even apologise when they are unable to do so. They have never been rude or arrogant.

There have been several concerns posted about software protection. We know data is encrypted and CE marked but there are other questions to be asked. For example if we are to market in Asia and/or US what safeguards are there?

Last October Dr Alastair Riddell said in an interview that we've raised money to invest in FDA approval (for Texrad) a process started and expected to take 9-12 months and they have engaged a US regulatory expert to help us.

Or if you prefer to stick to RNS announcements:-

" To fund regulatory consultant commission costs in relation to the Company's plans to secure regulatory approval of TexRAD® with the US FDA, including 510k as a medical device and CFR Chapter 21 part 11 compliance for use in clinical trials of drug candidates for FDA marketing approval

· To develop the Company's partnership with Imaging Endpoints, its US imaging company partner, in order to maximise its sales in the US"

How do we maximise sales in the US without FDA approval?

So tell me what is wrong with asking how we are progressing with that? How long would it take to answer? Salaries may not be massive but they asked us to grant millions of options!

Why do we have to to be careful about what we expect from TO? He is the CEO of a listed company who is about to have more options granted. He has yet to put any money into this company by buying shares.

Are we really acting in the best interest of the company? It is up to the company to act in its own best interests; it is up to shareholders to look after theirs.

As I said earlier there have been several posts about protection and FDA approval. The company could act in its own interests by answering honestly and putting these questions to bed.

If you want to lie down and be walked all over so be it. I put the counter argument that we should bombard them with emails until they give honest answers.

[hazl] 24/8/2019 10:51

Good find dplewis!

[dplewis1] 24/8/2019 09:28

https://www.med-technews.com/api/amp/features/how-a-messaging-service-doubles-up-as-a-medical-device/?

[ducatiman] 23/8/2019 19:39

Emails were directed to the company not TO. I believe, looking at the wage costs, that they have more than 1 employee! Obviously too busy making sales, which is fine.

[hazl] 23/8/2019 18:59

Very true davydoo.

[hazl] 23/8/2019 18:59

Well I have made comments on the Twitter site for Bleepa and they have been answered directly and cheerfully!
So perhaps that is the way forward?

[davydoo] 23/8/2019 18:29

I think we've got to be careful about what we expect from TO

If everybody with a 1% holding wants an on demand personal dialogue with the ceo at the same time as he's preparing for the company's potentially biggest ever product launch, are we really acting in the best interest of the company?

[ducatiman] 23/8/2019 18:05

Good post George, I am still waiting for a reply to an email I sent them a couple of months ago.
Let's hope TO doesn't learn too much from AR but is his own man and can make progress and changes.
If bleepa takes off he will have the time and resources to do so and has other products with huge potential to work with.
GLA, duc.

[hazl] 23/8/2019 15:10

Security is treated as an important issue these days.